Direct-access lab testing gives eligible adults a way to order selected laboratory tests online without first arranging a conventional office visit solely to request the order. A responsible process starts with a focused question, verifies that the test and collection route are appropriate, follows exact preparation instructions, and includes a plan for reviewing and acting on the result.
Laboratory testing can provide objective information for screening, baseline assessment, or monitoring, but it does not provide individualized diagnosis or treatment by itself. It cannot replace emergency care, a medical history and physical examination, imaging, biopsy, culture, functional testing, or specialist evaluation when those are needed.[1][2]
Do not delay urgent care. Severe, sudden, rapidly worsening, or potentially life-threatening symptoms require prompt medical evaluation. Call 911 or seek urgent care for possible heart attack, stroke, sepsis, severe breathing difficulty, major bleeding, new confusion, fainting, or urgent pregnancy and postpartum warning signs.[7][8][9]
This cornerstone explains the ordering pathway. Use the related cornerstone guides to understand what laboratory tests measure and how reports should be interpreted:
Direct-access laboratory testing is a pathway through which an eligible person may obtain selected laboratory testing without first scheduling a traditional office visit solely to ask for that test. The exact authorization, collection, and reporting process varies by service, product, specimen, jurisdiction, and individual eligibility.
Patient-directed testing means the patient initiates the request. A licensed clinician or another authorized process may still review or authorize the laboratory order when required. Laboratory authorization is the valid order or requisition needed for a laboratory to perform testing. Specimen collection is the process of obtaining blood, urine, stool, saliva, a swab, or another specimen under the instructions for the selected test.
Direct-to-consumer testing is a broader term used for tests marketed directly to consumers. Some models use a home-collected specimen; others use in-person collection and testing through a clinical laboratory. The label alone does not establish that a test is appropriate, available, clinically useful, or self-interpreting. Confirm the exact authorization, specimen, collection route, method, limitations, and follow-up needs before ordering.[1][2]
| It may help | It generally cannot replace | Professional care is especially important when |
|---|---|---|
| Establish a baseline for a defined question. | A personal medical history and physical examination. | Symptoms are severe, sudden, progressive, recurrent, or unexplained. |
| Repeat a previously measured marker under comparable conditions. | Diagnosis based on the full clinical picture. | A result could change a prescription, dose, procedure, fertility plan, or pregnancy-related decision. |
| Support an appropriate screening or risk-assessment question. | Imaging, endoscopy, biopsy, culture, electrocardiography, sleep studies, or other functional testing. | A screening result is positive, borderline, indeterminate, unexpected, or inconsistent with symptoms. |
| Prepare objective information for a healthcare appointment. | Urgent or emergency evaluation. | There is a complex medical history, significant organ disease, multiple medicines, or a high-risk condition. |
| Track a professionally guided lifestyle or treatment plan. | Individualized treatment recommendations or medication management. | Cancer, serious infection, genetic findings, pregnancy, or specialist-directed testing is involved. |
| Identify whether further evaluation may be warranted. | Proof that an abnormal value is caused by one particular disease. | The report includes a critical-result instruction or the person feels acutely unwell. |
Some eligible adults may consider direct-access testing when the question is focused, the test is available, preparation can be followed, and a realistic follow-up plan exists. Examples include:
Direct access is not appropriate for every person or concern. Its value depends on whether the result can answer a meaningful question and whether the patient has a responsible plan for interpretation and follow-up.
Eligible adult students may use direct-access testing for a focused, nonurgent purpose. Examples include a school- or clinical-program-requested immunity test, a previously defined repeat measurement, a focused sexual-health screening, or objective information to review with campus health or another healthcare professional. Direct-access testing should complement—not replace—campus health, primary care, mental-health services, vaccinations, treatment, or urgent evaluation.
Before ordering, verify the exact test name, biomarkers, specimen type, accepted documentation, timing, and deadline with the institution. A product described as an immunity or titer panel should not automatically be assumed to satisfy a particular school, clinical rotation, employer, internship, or licensing requirement. Depending on the disease and organization, acceptable evidence may include vaccination records, laboratory evidence of immunity, or another defined form of documentation.[10][11]
| Test or route and quick facts | What it may help document | Preparation, acceptance, and limitations |
|---|---|---|
| Student Health Titers Base Panel Use status: Requirement-dependent bundled option | Combines several commonly requested immunity-related measurements in one order. | Panel contents and institutional acceptance can differ. Compare every included biomarker with the written requirement before purchase. |
| Measles, Mumps, Rubella (MMR) Immunity Profile Use status: Institution-specific | Measures disease-specific IgG antibodies that may be used as laboratory evidence of immunity in some settings. | A positive or negative result does not replace the institution’s policy. Verify whether records, vaccination, or a specific assay is required. |
| Hepatitis B Surface Antibody Quantitative Test Use status: Institution-specific | Measures the amount of hepatitis B surface antibody and may be requested for healthcare training or occupational documentation. | Interpretation depends on vaccination history, exposure context, timing, and the program’s threshold or follow-up policy. |
| Varicella Zoster Virus Antibody Immunity Screen Use status: Institution-specific | Assesses varicella-zoster antibody evidence that may be used for immunity documentation. | Assays differ, and vaccination-induced immunity may require a specifically accepted method. Confirm the institution’s exact requirement. |
| QuantiFERON-TB Gold Plus Tuberculosis Test Use status: Risk- and requirement-based | An interferon-gamma release assay used to evaluate immune response to tuberculosis antigens. | It does not determine active disease by itself. Symptoms, exposure risk, immune status, and follow-up imaging or clinical evaluation may be needed. |
Students considering infectious-disease, immunity, titer, or STI testing should review the Infectious Disease Testing pillar for specimen, exposure-timing, window-period, and follow-up limitations. Website access may be available at any time, but specimen collection occurs only during the selected site’s operating hours and is subject to appointment, specimen, and location requirements. Result timing varies by test.
Students under the age of majority: Ordering eligibility, consent, parent or guardian involvement, and pediatric-care requirements depend on the person’s age, location, test, and circumstances. Direct-access testing should not be presented as a way for a minor to bypass applicable consent or clinical-care requirements.
Do not use routine online testing to delay emergency or time-sensitive care. Call 911 or seek prompt medical attention for chest pressure or pain, significant trouble breathing, fainting, sudden weakness or speech difficulty, sudden severe headache, major bleeding, new confusion, severe pain, or other potentially life-threatening changes.[7][9]
Direct-access testing is generally not the right first step when:
An individual test may be appropriate for a repeated marker or narrow question. A focused panel combines related measurements that add necessary context. For example, a Complete Blood Count with Differential and Platelets (CBC) provides related blood-cell measurements, while a Comprehensive Metabolic Panel (CMP) combines chemistry markers related to glucose, electrolytes, proteins, kidney context, and liver context. These panels answer different questions and should not be treated as interchangeable.
More testing is not automatically better. Broad testing increases the chance of incidental findings, false-positive or borderline results, duplicated recent measurements, unnecessary anxiety, and follow-up that may not improve care.[12]
| Role | Purpose | Important boundary |
|---|---|---|
| Baseline | Documents a starting measurement before a planned comparison. | A baseline is not a diagnosis and may not need frequent repetition. |
| Screening | Looks for risk or a possible finding before a condition is established. | A positive or borderline screen may require a different confirmatory test or professional evaluation. |
| Monitoring | Follows a known marker, condition, treatment, or professionally defined plan. | The interval, preparation, timing, method, and action thresholds should be defined. |
| Diagnostic support | Contributes evidence when symptoms or other findings are already present. | A laboratory result is one part of the evaluation and rarely establishes the diagnosis by itself. |
| Documentation | Provides a result requested by a school, program, employer, or other organization. | The requesting organization—not the product name—determines what documentation it will accept. |
Availability varies by test, specimen, authorization model, collection network, and jurisdiction. Ulta Lab Tests currently does not offer its direct-access service in New York, New Jersey, Rhode Island, or Hawaii. Eligibility and restrictions can change, so review How It Works and confirm checkout eligibility before purchasing.
Not every patient service center performs every specimen type or specialty collection. Use the patient service center locator and confirm the location’s hours, appointment policy, age restrictions, order acceptance, and specimen capability before traveling.
Preparation should be based on the exact order—not on a generic rule. Many tests require no special preparation. Others may be affected by food, drinks, hydration, collection time, exercise, acute illness, menstrual-cycle timing, medicines, vitamins, supplements, or specimen handling.[3][4]
| Preparation factor and linked examples | Why it may matter | Patient action and important limitations |
|---|---|---|
| Fasting Examples: Glucose Test, Lipid Panel Test, Ferritin, Iron and Total Iron-Binding Capacity Panel | Food and beverages can change circulating glucose, triglycerides, iron measurements, and other analytes. | Fast only when the exact instructions require it. Confirm the duration and permitted intake. Do not extend a fast unnecessarily; diabetes, pregnancy, eating disorders, and medication timing may require individualized guidance. |
| Hydration Examples: CBC, CMP, Urinalysis Complete | Dehydration or unusual fluid intake may change concentration and can make blood collection more difficult. | Maintain usual hydration unless instructed otherwise. Do not force excessive water, and follow any prescribed fluid restriction. |
| Time of day Examples: Cortisol Total Test, Testosterone Total Test, Prolactin Test | Some hormones and other analytes change during the day. | Collect at the instructed time and document timing for comparisons. “Morning is best” is not a universal rule. |
| Exercise Examples: Creatine Kinase Total Test, AST Test, Lactate Dehydrogenase Test, Creatinine Test, Albumin Random Urine Test with Creatinine | Strenuous activity can temporarily affect muscle enzymes, kidney-related markers, hormones, lactate, and urine protein. | Avoid or standardize exercise only as directed. Do not delay evaluation of severe muscle pain, weakness, or dark urine. |
| Menstrual-cycle or reproductive timing Examples: Estradiol Test, Progesterone Test, FSH Test, LH Test, AMH Test Female | Cycle phase, age, pregnancy status, fertility treatment, and hormone therapy can change interpretation. | Follow the timing requested for the specific question and record the cycle day, pregnancy status, and relevant therapy. |
| Acute illness and inflammation Examples: C-Reactive Protein Test, Sed Rate Test, Ferritin Test | Infection, inflammation, injury, and recent procedures may temporarily alter inflammatory and iron-related markers. | Document recent illness or procedures. Do not assume that an elevated nonspecific marker identifies the cause. |
| Medicines, vitamins, supplements, and biotin Test-specific effects vary. | A product may change the underlying biology or interfere with a laboratory method. High-dose biotin can interfere with some immunoassays. | Provide a complete list. Follow test-specific or professional instructions. Never stop or change a medicine on your own to prepare for testing.[5] |
| Specimen instructions Urine, stool, saliva, swab, timed urine, and specialty-kit tests | Collection technique, timing, labeling, storage, contamination, and transport can affect validity. | Read all instructions before starting. Use the supplied container and follow labeling, timing, storage, and transport requirements exactly. |
Medication safety: Do not start, stop, delay, or change a prescription medicine solely because of an online article, product description, or one laboratory result. Contact the prescribing professional when medication timing or monitoring affects the order.
Procedures vary by location and specimen, but an in-person visit may include:
A routine venous blood draw usually involves cleaning the skin, inserting a needle into a vein, filling one or more tubes, removing the needle, and applying pressure. Mild, brief discomfort or bruising can occur. Tell collection staff about a history of fainting, difficult blood draws, bleeding problems, or accessibility needs.
Urine, stool, saliva, swab, and timed specimens require exact technique. Contamination, incorrect timing, the wrong container, insufficient volume, mislabeling, transport delay, or temperature problems can lead to rejection or unreliable results. A rejected specimen or missing result is not a negative result.
Result timing varies substantially by test, specimen, method, laboratory schedule, reflex testing, confirmation needs, and specimen quality. Do not rely on one universal turnaround promise. Use View and Track Your Results and contact support when a result is incomplete or overdue based on the product-specific information.
Reference intervals describe values observed in a defined comparison population. They are not always the same as diagnostic thresholds, treatment goals, or individualized monitoring targets. A flagged result may be temporary or clinically unimportant, while a value inside a reference interval may still deserve attention in the right context. Use How to Read and Understand Your Lab Results for a deeper framework.[6]
Repeat or confirmatory testing may be appropriate when:
Repeat testing should answer a question. It should not become an automatic response to every minor flag. When repeating, use comparable preparation, timing, specimen, and method when possible and follow the professional plan.
| Topic | Current patient-facing process | Important limitation or next step |
|---|---|---|
| Pricing | Review the listed price and order details before checkout. | Prices, promotions, eligibility, and collection arrangements can change. Verify the final order before payment. |
| Insurance | Ulta Lab Tests does not accept insurance or file insurance claims. | Review the current Patient Terms and Conditions before attempting reimbursement or using insurance-related documentation. |
| HSA/FSA | HSA and FSA cards are accepted for eligible services. | Card acceptance does not guarantee that every test or purchase is a qualified expense under every account, plan, or tax rule. |
| Refunds and cancellations | Review the Return and Refund Policy before ordering or cancelling. | Eligibility, timing, fees, and exceptions are governed by the policy in effect for the transaction. |
| Privacy | Ulta publishes a Website Privacy Policy and a separate Notice of Privacy Practices. | Read both documents for the current handling of website information and protected health information. Do not infer broader guarantees. |
| Results | Reports are accessed through the patient account using View and Track Your Results. | Timing varies by test. Protect account credentials and contact support if the report appears incomplete. |
| Locations | Use the patient service center locator. | Confirm hours, appointment policy, age restrictions, order acceptance, and specimen capability before visiting. |
Ulta Lab Tests accepts Health Savings Account (HSA) and Flexible Spending Account (FSA) payment cards for eligible services. That operational acceptance does not mean every available test automatically qualifies for tax-free payment or reimbursement. IRS guidance generally recognizes laboratory fees as medical expenses when they are part of medical care, but the purpose of the expense and the rules of the account or plan still matter.[13][14]
| Account or situation | General distinction | What to verify |
|---|---|---|
| HSA | An individually owned tax-advantaged account generally associated with HSA eligibility requirements. Unused balances generally remain in the account. | Confirm that the expense is qualified, retain records, and review current IRS rules or seek tax advice for your situation. |
| Health FSA | An employer-established benefit subject to the employer plan’s terms. Plan-year deadlines, grace periods, or permitted carryovers may apply. | Review the plan document and claim deadline before relying on reimbursement or a spending deadline. |
| Spouse or dependent expense | Some qualified medical expenses for a spouse or qualifying dependent may be eligible, depending on account and tax rules. | Confirm the person’s eligibility and the documentation required before ordering. |
| General wellness purchase | A product being broadly health-related does not automatically make it a qualified medical expense. | Confirm that the expense meets the applicable medical-care and plan requirements rather than assuming all testing is eligible. |
Important HSA/FSA limitation: Do not state that all Ulta tests are automatically HSA- or FSA-eligible. Eligibility depends on the specific expense and applicable account, plan, and tax rules. Contact the plan administrator or a qualified tax professional for individual guidance.
Use the most relevant guide to understand test selection, limitations, preparation, and follow-up for a defined health question.
Ulta Lab Tests provides an online pathway for eligible patients to search available lab tests, complete an eligible order, obtain the laboratory requisition, find a patient service center, and view and track results through the patient account.
The service may help a patient obtain objective information for a baseline, a planned repeat measurement, a focused screening question, a verified documentation requirement, or a more informed healthcare conversation. Product descriptions and health guides can help compare options, but they cannot determine the correct test for every person or replace professional care.
Before ordering, verify the exact product, included biomarkers, preparation, specimen, location, price, authorization, limitations, and follow-up process. For operational questions, review How It Works, the Frequently Asked Questions, and the current policy pages linked above.
The following products are linked because they illustrate focused testing questions discussed in this guide. This directory is educational, not a recommendation that every reader order every test. Product availability, preparation, specimen requirements, method, price, and clinical use can change. Open the exact product page before ordering.
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Complete Blood Count with Differential and Platelets (CBC) Use status: Common foundational panel | Measures red-cell, white-cell, differential, and platelet parameters that may support evaluation of anemia, infection-related patterns, inflammation, and blood-cell disorders. | Hydration, recent illness, altitude, pregnancy, medicines, and specimen factors can influence components. A CBC does not identify the cause of an abnormal cell count by itself. |
| Comprehensive Metabolic Panel (CMP) Use status: Common foundational chemistry panel | Combines glucose, electrolytes, proteins, kidney-related measurements, and liver-related measurements for broad chemistry context. | Food intake, hydration, illness, medicines, and collection conditions can affect components. A CMP is not a stand-alone diagnosis of kidney, liver, or metabolic disease. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Hemoglobin A1c (HbA1c) Test Use status: Common or risk-based | Estimates average glucose exposure over roughly the prior two to three months and may support diabetes screening or monitoring. | Conditions that alter red-cell lifespan, hemoglobin variants, blood loss, transfusion, kidney disease, and pregnancy can affect interpretation. |
| Glucose Test Use status: Common or risk-based | Measures blood glucose at the collection time and may be used in screening, diagnostic support, or monitoring. | Fasting status, recent food, stress, illness, exercise, and medicines can affect the result. One value must be interpreted in context. |
| Insulin Test Use status: Focused or risk-based | Measures circulating insulin and may contribute to selected evaluations of glucose regulation or insulin production. | Timing relative to food, glucose, medicines, and the clinical question matters. It is not a universal screening test. |
| C-Peptide Test Use status: Focused or specialist-guided | Reflects endogenous insulin production and may help distinguish selected causes of abnormal glucose regulation. | Glucose at the time of collection, kidney function, food intake, and diabetes treatment affect interpretation. |
| Lipid Panel Test Use status: Common cardiovascular assessment | Measures cholesterol-related components and triglycerides used in cardiovascular-risk assessment and monitoring. | Fasting may or may not be required depending on the order and purpose. Illness, alcohol, diet, medicines, and recent weight change can influence values. |
| Apolipoprotein B Test (ApoB) Use status: Risk-based adjunct | Estimates the number of atherogenic lipoprotein particles and may refine cardiovascular-risk assessment in selected people. | Not required for every person. Interpret with the lipid profile, history, treatment status, and overall risk. |
| Lipoprotein(a) Test Use status: Risk-based adjunct | Measures an inherited lipoprotein-related risk marker that may add context to cardiovascular risk. | Levels are largely genetically influenced. It does not diagnose cardiovascular disease or determine treatment by itself. |
| C-Reactive Protein Test (CRP) Use status: Focused nonspecific inflammation marker | Measures an acute-phase protein that may rise with infection, inflammation, injury, or other conditions. | CRP is nonspecific and cannot identify the cause or location of inflammation. Timing and recent illness matter. |
| Sed Rate Test (ESR) Use status: Focused nonspecific inflammation marker | Measures the rate at which red cells settle and may support evaluation or monitoring of selected inflammatory conditions. | Age, anemia, pregnancy, infection, immunoglobulins, and other factors can affect ESR. It is not disease-specific. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Creatinine Test Use status: Common kidney-related marker | Measures serum creatinine, often used to estimate glomerular filtration and assess kidney context. | Muscle mass, diet, hydration, exercise, medicines, and acute illness can affect creatinine. Estimated filtration is not a direct measurement. |
| Cystatin C with eGFR Use status: Focused adjunct | Uses cystatin C to estimate filtration and may add context when creatinine-based estimates are uncertain. | Inflammation, thyroid status, corticosteroid use, body composition, and method can affect interpretation. |
| Albumin Random Urine Test with Creatinine (uACR) Use status: Common or risk-based urine marker | Estimates urine albumin relative to creatinine and may detect or monitor kidney damage risk. | Exercise, fever, infection, menstruation, blood pressure, glucose, and collection conditions can transiently affect the result; persistence may need confirmation. |
| Urinalysis Complete Use status: Common focused urine assessment | Examines chemical and microscopic urine findings that may support evaluation of urinary, kidney, metabolic, or infectious questions. | Collection quality and contamination matter. A urinalysis may require culture, imaging, or clinical evaluation depending on the finding. |
| Protein Total, 24-Hour Urine Test with Creatinine Use status: Focused or specialist-guided | Measures total urine protein over a timed collection and uses creatinine to help assess collection completeness. | Every void during the collection period must be included and stored as instructed. Incomplete timing can invalidate interpretation. |
| Uric Acid Test Use status: Focused or risk-based | Measures blood uric acid and may contribute to gout, kidney-stone, treatment-monitoring, or metabolic questions. | A value alone does not diagnose or exclude a gout flare. Diet, alcohol, medicines, kidney function, and timing can affect the result. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Hepatic Function Panel Use status: Common or risk-based panel | Combines enzymes, bilirubin, and proteins used to assess liver-related patterns and monitoring questions. | Exercise, medicines, alcohol, illness, muscle injury, and other conditions can affect components. The panel does not identify every liver disease or determine fibrosis by itself. |
| Bilirubin Total Test Use status: Focused or panel component | Measures total bilirubin and may support evaluation of jaundice, red-cell breakdown, or liver and bile-flow patterns. | Fasting, illness, genetic conditions, hemolysis, and specimen handling can influence interpretation. |
| AST Test Use status: Focused or panel component | Measures an enzyme found in liver, muscle, heart, and other tissues. | AST is not liver-specific. Strenuous exercise or muscle injury may elevate it, so related markers and context matter. |
| Creatine Kinase Total Test (CK) Use status: Focused muscle marker | Measures a muscle-associated enzyme and may support evaluation of muscle injury, symptoms, or selected medication-monitoring questions. | Strenuous exercise, injections, trauma, body composition, and medicines can raise CK. Severe symptoms may require urgent care. |
| Lactate Dehydrogenase Test (LDH) Use status: Focused nonspecific marker | Measures an enzyme present in many tissues and may contribute to selected evaluations of tissue injury or disease monitoring. | LDH is nonspecific and can be affected by specimen hemolysis. It rarely identifies the source of a problem by itself. |
| Lactic Acid Plasma Test Use status: Clinically contextual or urgent-care-associated | Measures lactate and may be used in specific metabolic, perfusion, or illness evaluations. | Collection technique, tourniquet time, exercise, transport, and acute illness matter. Concerning symptoms should not be evaluated through delayed routine ordering. |
| Catecholamines, Fractionated, Plasma Test Use status: Specialist-directed or focused | Measures plasma catecholamines for selected endocrine or autonomic questions. | Posture, stress, exercise, medicines, food, and collection conditions can materially affect results. Test selection and preparation often require professional guidance. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| TSH Test Use status: Common thyroid-function marker | Measures thyroid-stimulating hormone and is commonly used in thyroid screening or monitoring. | Illness, pregnancy, medicines, biotin, age, and treatment timing can affect interpretation. TSH may need free hormone tests for context. |
| Free T4 Test Use status: Common focused thyroid marker | Measures unbound thyroxine and may help interpret thyroid function with TSH. | Pregnancy, binding-protein changes, illness, medicines, and assay interference can affect results. |
| Free T3 Test Use status: Focused thyroid marker | Measures unbound triiodothyronine and may be useful in selected thyroid questions. | It is not required for every thyroid evaluation and can be affected by illness, medicines, and assay variation. |
| Thyroid Peroxidase Antibodies Test (TPO) Use status: Risk-based autoimmune marker | Measures antibodies associated with autoimmune thyroid disease and may add cause or risk context. | A positive antibody result does not establish current thyroid dysfunction, and a negative result does not exclude every thyroid disorder. |
| Cortisol Total Test Use status: Time-sensitive focused test | Measures total cortisol at the collection time and may contribute to selected adrenal questions. | Time of day, stress, sleep, illness, pregnancy, estrogen exposure, medicines, and the diagnostic pathway strongly affect interpretation. |
| Prolactin Test Use status: Focused hormone test | Measures prolactin and may support evaluation of menstrual, fertility, breast, pituitary, or medication-related questions. | Stress, sleep, pregnancy, breast stimulation, exercise, medicines, and macroprolactin can affect results. |
| Estradiol Test Use status: Cycle-, age-, and treatment-dependent | Measures estradiol and may support reproductive, menopause, fertility, or hormone-treatment questions. | Cycle day, pregnancy, age, therapy, and assay sensitivity matter. One result rarely defines reproductive or menopausal status by itself. |
| Progesterone Test Use status: Timing-dependent | Measures progesterone and may support selected ovulation, fertility, or pregnancy-related questions. | Collection timing relative to ovulation or treatment is essential. A single result has limited meaning without the correct timeline. |
| FSH Test Use status: Focused reproductive hormone test | Measures follicle-stimulating hormone for selected reproductive, ovarian, testicular, or pituitary questions. | Age, cycle day, pregnancy, hormone use, and pulsatile secretion affect interpretation. |
| LH Test Use status: Focused reproductive hormone test | Measures luteinizing hormone and may support ovulation, gonadal, or pituitary evaluation. | Cycle timing, pregnancy, medicines, and pulsatile release matter. It should be interpreted with the clinical question and related hormones. |
| AMH Test Female Use status: Focused ovarian-reserve marker | Measures anti-Müllerian hormone and may contribute to ovarian-reserve and fertility-treatment planning. | AMH does not measure egg quality, predict natural conception with certainty, or diagnose infertility by itself. Assay and treatment context matter. |
| Testosterone Free, Bioavailable, and Total Test Use status: Focused hormone assessment | Measures several testosterone-related values that may add context when binding proteins or symptoms complicate interpretation. | Collection time, age, illness, obesity, medicines, hormone therapy, and assay method matter. Diagnosis generally requires compatible symptoms and appropriate confirmation. |
| Sex Hormone Binding Globulin Test Use status: Adjunct hormone marker | Measures a binding protein that influences total and free sex-hormone interpretation. | Thyroid status, liver disease, weight, insulin resistance, pregnancy, and hormone therapy can affect SHBG. |
| PSA Total Test Use status: Shared-decision or monitoring test | Measures prostate-specific antigen and may be used in prostate cancer screening discussions or monitoring. | PSA is not cancer-specific. Age, prostate size, infection, inflammation, procedures, ejaculation, medicines, and screening preferences matter. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Ferritin Test Use status: Common or risk-based iron marker | Measures ferritin, a protein used to assess stored iron and interpret iron deficiency or overload questions. | Inflammation, infection, liver disease, metabolic conditions, and other factors can elevate ferritin. It should not be interpreted alone. |
| Iron and Total Iron-Binding Capacity Test Use status: Focused iron assessment | Measures circulating iron and binding capacity used to interpret transferrin saturation and current iron availability. | Time of day, fasting status, supplements, recent iron intake, illness, and laboratory method can influence values. |
| Vitamin B12 Test Use status: Common or risk-based nutrient test | Measures circulating vitamin B12 and may support evaluation of anemia, neuropathy, malabsorption, diet, or medication-related risk. | A borderline result may require functional markers or additional evaluation. Supplements and recent injections can affect the value. |
| Folate Serum Test Use status: Focused nutrient test | Measures serum folate and may support evaluation of macrocytosis, deficiency risk, or nutritional status. | Recent intake and supplementation can influence serum folate. It does not identify the cause of an abnormal blood count by itself. |
| Vitamin D 25-Hydroxy Total Test Use status: Risk-based or monitoring test | Measures the main circulating form used to assess vitamin D status. | Supplement use, season, body composition, malabsorption, kidney or liver disease, and assay method matter. More testing or supplementation is not automatically better. |
| Magnesium Test Use status: Focused mineral test | Measures serum magnesium and may support evaluation of electrolyte, medication, gastrointestinal, or kidney-related questions. | Serum magnesium may not reflect total-body stores. Kidney function, medicines, illness, and specimen hemolysis can affect interpretation. |
| Zinc Test Use status: Focused mineral test | Measures circulating zinc and may contribute to selected deficiency, malabsorption, nutrition, or exposure questions. | Time of day, fasting, inflammation, albumin, supplements, and trace-element collection technique can affect results. |
| Test and quick facts | What it shows and how it is used | Preparation, influences, and limitations |
|---|---|---|
| Student Health Titers Base Panel Use status: Requirement-dependent bundle | Groups commonly requested immunity-related measurements for some student or clinical-program documentation needs. | Verify every component and accepted assay against the institution’s written requirement. Do not assume one bundle fits every program. |
| Student Titers Panel Use status: Requirement-dependent bundle | Provides another bundled route for selected immunity-documentation questions. | Panel composition may differ from other similarly named products. Compare biomarkers, specimen, and institution policy before ordering. |
| MMR Immunity Profile Use status: Institution-specific | Measures measles, mumps, and rubella IgG antibodies that may be used as laboratory evidence of immunity. | Institutional policy determines whether serology, vaccination records, or another action is accepted. |
| Hepatitis B Surface Antibody Quantitative Test Use status: Institution-specific | Quantifies hepatitis B surface antibody for selected immunity or response documentation. | Vaccination history, exposure, immune status, timing, and program-specific thresholds affect follow-up. |
| Varicella Immunity Screen Use status: Institution-specific | Assesses laboratory evidence of varicella-zoster immunity. | Assays and institutional acceptance differ, particularly for vaccine-induced immunity. Verify the required method. |
| QuantiFERON-TB Gold Plus Tuberculosis Test Use status: Risk- or requirement-based | Evaluates immune response to tuberculosis antigens and may be used for school, clinical, employment, or exposure-related screening. | A positive or indeterminate result requires appropriate clinical follow-up; it does not diagnose active tuberculosis by itself. |
Eligible adults may be able to initiate selected laboratory orders through a direct-access service. Availability depends on the test, authorization pathway, state, specimen, collection location, and individual eligibility.
Often, yes. Direct access changes how an eligible test is obtained; it does not replace professional care for severe or unexplained symptoms, complex history, medication decisions, pregnancy concerns, unexpected results, diagnosis, or treatment.
Start with one focused question, review the product’s intended use and limits, consider prior results and relevant history, and choose the minimum sufficient option. Seek professional help when several conditions are possible or the result could change treatment.
Not necessarily. A related panel may add useful context, but a larger panel can add unrelated markers, duplicate recent testing, increase cost, and create incidental findings. Choose the smallest set that adequately addresses the question.
Only when the exact test instructions require it. Many tests do not require fasting. Confirm the duration and permitted intake; follow the order rather than a generic rule.[4]
Yes. Medicines and supplements may change the measured biology or interfere with a method. Provide a complete list and follow test-specific or professional instructions. Never change a prescription on your own to prepare for testing.
Bring the required photo identification, requisition or order confirmation, and any site-specific documents. Confirm the location, hours, appointment policy, age restrictions, and specimen capability before visiting.
You may need a corrected order, a different location, or repeat collection. Contact the ordering service for instructions. A rejected specimen or missing result is not a negative result.
Ulta Lab Tests provides results through the patient account. Use View and Track Your Results. Delivery time varies by test; protect account credentials and contact support if a result appears incomplete.
Read the value, unit, reference information, comments, related markers, and urgent instructions. Consider preparation and prior results. Do not self-diagnose or change treatment. Arrange professional review; repeat or confirmatory testing may be needed.
No. Availability and requirements vary. Ulta currently does not offer its direct-access service in New York, New Jersey, Rhode Island, or Hawaii. Recheck How It Works and checkout eligibility before ordering.
Ulta accepts HSA and FSA cards for eligible services. The eligibility of a particular expense is governed by the applicable account, plan, and tax rules. Keep an itemized receipt and confirm requirements with the plan administrator.
Possibly. Some plans allow a customer to pay with another method and submit an itemized receipt and supporting documentation. Reimbursement procedures and deadlines vary by plan.
Depending on account and tax rules, an eligible medical expense for a spouse or qualifying dependent may be reimbursable. Confirm the person’s eligibility and documentation requirements before ordering.
Eligible adult students may be able to obtain requested immunity, titer, tuberculosis, infectious-disease, or other laboratory testing. Confirm the exact test, biomarkers, assay, specimen, and documentation accepted by the institution before purchasing.
The website and online ordering pathway may be accessible outside ordinary business hours. Specimen collection occurs during the selected site’s operating hours and remains subject to appointment, order, age, specimen, and location requirements. Laboratory processing and result timing also vary.
Eligibility and consent rules vary by location, test, and age. Parents or guardians should verify the applicable requirements, and pediatric evaluation should not be bypassed when individualized care is needed.
Testing should never delay urgent or emergency evaluation for severe, sudden, rapidly worsening, or potentially life-threatening symptoms, including possible heart attack, stroke, sepsis, severe breathing difficulty, major bleeding, or urgent pregnancy and postpartum warning signs.
Responsible direct-access lab testing follows a clear sequence: define the question, confirm that the situation is nonurgent, choose a focused option, verify the exact order, prepare correctly, complete specimen collection, review the report in context, and arrange appropriate follow-up.
Testing gains value from relevance and context—not volume. Use The Complete Guide to Lab Tests and Blood Work to understand tests and panels, and use How to Read and Understand Your Lab Results to evaluate values, ranges, flags, patterns, and trends. Then use the health pillars above for focused education related to the question you are trying to answer.
Ulta Lab Tests provides direct-access laboratory testing. Product links are included when they match the educational topic. Purchasing a test is not a substitute for diagnosis, treatment, or urgent medical care.
Written by: John R. | Originally published: August 1, 2026 | Last updated: August 11, 2026
Medical note: This guide is educational. A qualified healthcare professional should select and interpret testing in the context of symptoms, diagnoses, medicines, pregnancy status, nutrition, hydration, and prior results. Do not start, stop, or change a prescription based on this article or one laboratory result.
These two panel links represent several component terms used in the article, including blood counts, hemoglobin, hematocrit, red-cell indices, white-cell differential, platelets, electrolytes, AST, bilirubin, and proteins.
The lipid-panel link covers the article’s references to cholesterol and triglycerides. A1C, glucose, insulin, and C-peptide answer different metabolic questions and should not be treated as interchangeable. ApoB, Lp(a), CRP, and ESR provide different cardiovascular or inflammatory information and are not universal screening tests for every reader.
These links cover creatinine, estimated filtration, cystatin C, urine albumin-to-creatinine ratio, urinalysis, urine protein, and uric acid. Kidney findings often need to be interpreted together rather than from one isolated measurement.
The hepatic panel represents the article’s references to liver enzymes, AST, bilirubin, and proteins. CK, LDH, lactate, creatinine, catecholamines, and urine protein can be affected by exercise or collection conditions, which is why they appear in the preparation matrix.
The article discusses these tests as related but distinct measurements. A thyroid-antibody result does not replace thyroid-function testing, and one thyroid result should not ordinarily be interpreted in isolation.
Timing, menstrual-cycle phase, age, pregnancy, medicines, hormone therapy, illness, and the reason for testing can materially affect how these results are used. FSH, LH, AMH, testosterone, SHBG, and PSA answer different clinical questions and should not be presented as one interchangeable “hormone panel.”
Ferritin, serum iron, TIBC, and related iron measurements provide different information. Nutrient blood tests may help answer focused questions but do not always reflect total-body stores, tissue status, dietary quality, absorption, or the cause of an abnormal result. Magnesium and zinc results also require clinical and specimen context.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
